ROYCE & ASSOCIATES LP - CUMBERLAND PHARMACEUTICALS I ownership

CUMBERLAND PHARMACEUTICALS I's ticker is CPIX and the CUSIP is 230770109. A total of 46 filers reported holding CUMBERLAND PHARMACEUTICALS I in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of CUMBERLAND PHARMACEUTICALS I
ValueSharesWeighting
Q3 2015$84,000
-19.2%
14,6000.0%0.00%
Q2 2015$104,000
+33.3%
14,600
+24.8%
0.00%
Q1 2015$78,00011,7000.00%
Other shareholders
CUMBERLAND PHARMACEUTICALS I shareholders Q1 2015
NameSharesValueWeighting ↓
BRIDGEWAY CAPITAL MANAGEMENT, LLC 286,655$541,7780.01%
Renaissance Technologies 555,763$1,0500.00%
Oakworth Capital, Inc. 3,052$5,7680.00%
ACADIAN ASSET MANAGEMENT LLC 188,164$3540.00%
MORGAN STANLEY 11,274$21,3080.00%
BlackRock Inc. 110,990$209,7710.00%
Bank of New York Mellon Corp 75,268$142,2560.00%
Citadel Advisors 32,400$61,2360.00%
Citadel Advisors 6,400$12,0960.00%
Citadel Advisors 5,933$11,2130.00%
View complete list of CUMBERLAND PHARMACEUTICALS I shareholders